in the generation of autoantibodies.Ann NY Acad sci,1993,681:29 3 Aime-Sempe C,Cohen-Kaminsky S,Bruand C,et al.In vivo preferential usage of tCR V β 8 in Torpedo acetylcholine receptor immune response in the murine experimental model of myasthenia gravis.J Neuroimmunol,1995,58(2):191
4 Schonrich G,Kalinke U,Momburg F,et al.Down regulation of T cell receptors on self-reactive T cells as a novel mechanism for extra-thymic tolerance induction. cell,1991,65(2):293
5 Bacha P,Williams DB, Waters C,et al.Interleukin-2 receptor targeted cytotoxicity:interleukin-2 receptormediated action of a diph-theria toxin-related interleukin-2 fusion protein.J Exp Med,1988,167(2):612
6 Thompson PA,McAtee R,Infante AJ, et al.V β-specific immu-notoxin selectively kills acetylcholine receptor reactive T lymphocyts from mice with experimental autoimmune myasthenia gravis.Intern Immunol,1994,6(12):1807
7 Ahlberg R,Yi Q,Pirskanen R,et al.Treatment of myasthenia gravis with anti-CD4 antibody:improvement correlates to decreased T-cell autoreactivity.Neurology,1994,44(9):1732
8 Shenoy M,Baron S,Wu B,et al.IFN-α treatment suppresses the development of experimental autoimmune myasthenia gravis.J Immunol,1995,154(12):6203
9 Rein J, McIntosh KR,Drachman D.Acetylcholine receptor pre-sentation by B cells using heterobifunctional antibody conjugates.Ann NY Acad Sci,1993,(681):325
10 Souroujon MC, Carmon S, Fuchs S. Regulation of experimental autoimmune myasthynia gravis by synthetic peptides of the acetylcho-line receptor. Ann NY acad Sci, 1993, (681):332
11 Link J,Fredrikson S,Soderstrom M,et al.Organ-specific autoan-tigens induce transforming growth factor-β mRNA expression
in mononuclear cells in multipl sclerosis and myasthenia gravis.Ann Neurol,1994,35(2):197 12 Wu B,Shenoy M,Goluszko E,et al.TCR gene usage in experimental autoimmune myasthenia gravis pathogenesis.J Immunol,1995,154(7):3603
13 Kaul R
上一页 [1] [2] [3] [4] 下一页
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文